Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome

Diabetes Care

Volumn 32, Issue 1, 2009, Pages

  Escobar Morreale, Hector F ^a,b   Luque Ramí, Manuel ^a,b   San Millan, Jose L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ANTIANDROGEN; METFORMIN; UNCLASSIFIED DRUG; VASPIN;

BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; LETTER; OBESITY; OVARY POLYCYSTIC DISEASE;

ADIPOSE TISSUE; BARIATRIC SURGERY; FEMALE; HUMANS; OBESITY; POLYCYSTIC OVARY SYNDROME; SERINE PROTEINASE INHIBITORS; SERPINS; VISCERA;

EID: 64549129225     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1690     Document Type: Letter

References (4)

1. Escobar-Morreale HF, San Milla'n JL: Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab 18:266-272, 2007
2. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS: Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57:1501-1507, 2008
3. Luque-Ramirez M, Alvarez-Blasco F, Botella-Carretero JI, Martinez-Bermejo E, Lasuncion MA, Escobar-Morreale HF: Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 92:2453-2461, 2007
4. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M, Blü her M: Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377, 2008